Edition:
United Kingdom

Takara Bio Inc (4974.T)

4974.T on Tokyo Stock Exchange

1,509JPY
17 Nov 2017
Change (% chg)

¥21 (+1.41%)
Prev Close
¥1,488
Open
¥1,502
Day's High
¥1,519
Day's Low
¥1,493
Volume
460,000
Avg. Vol
377,220
52-wk High
¥1,664
52-wk Low
¥1,372

Latest Key Developments (Source: Significant Developments)

Wafergen Bio-Systems expects total revenue for Q4 2016 to be about $3.9 mln
Wednesday, 15 Feb 2017 

Wafergen Bio-systems Inc : Wafergen Bio-systems reports revenue growth in fourth quarter of 2016 . Sees FY 2016 revenue about $10.7 million . Wafergen Bio-Systems Inc - company expects total revenue for Q4 of 2016 to be approximately $3.9 million or a 62% increase .Wafergen Bio-Systems Inc - ended Q4 with cash of approximately $4.5 million, which includes initial $2.5 million advanced by Takara Bio USA Holdings, Inc.  Full Article

Takara Bio launches fully differentiated, Cellartis hiPS beta cells for research use
Wednesday, 24 Aug 2016 

Takara Bio Inc <4974.T> :Launch of fully differentiated, Cellartis hiPS beta cells for research use.  Full Article

Takara Bio completes share repurchase
Tuesday, 14 Jun 2016 

Takara Bio Inc <4974.T> :Says it completes repurchase of 477,600 shares of its common stock, for about 725 million yen in total, on June 14.  Full Article

Wafergen Bio-Systems and Takara Bio signs distribution agreement for Japan
Monday, 6 Jun 2016 

Wafergen Bio-systems Inc :Wafergen Bio-Systems and Takara Bio Inc Announce exclusive distribution agreement for japan.  Full Article

Wafergen to pay Takara Bio USA Holdings termination fee equal to $2 mln
Friday, 13 May 2016 

Wafergen Bio-Systems Inc :Upon termination of merger agreement co will be required to pay Takara Bio USA Holdings a cash termination fee equal to $2.0 million.  Full Article

Takara Bio unit to fully acquire WaferGen Bio-systems
Friday, 13 May 2016 

Takara Bio <4974.T>:Says its subsidiary Takara Bio USA Holdings Inc. signed a merger agreement to fully acquire WaferGen Bio-systems, Inc at up to $50 million.  Full Article

TAKARA BIO lists on TSE first section
Thursday, 31 Mar 2016 

TAKARA BIO INC:Says began listing on Tokyo Stock Exchange (TSE) first section from TSE Mothers on March 31.  Full Article

TAKARA BIO to list on TSE first section
Thursday, 24 Mar 2016 

TAKARA BIO INC:Says to list on Tokyo Stock Exchange (TSE) first section from March 31.  Full Article

BRIEF-Takara Bio say first patient enrolled into phase I clinical trial of Oncolytic Virus HF10 in Japan

* Says the first patient with pancreatic cancer has been enrolled into Oncolytic Virus HF10(TBI-1401) phase I clinical trial in Japan on Sept. 26